Ultra Health continues record growth pace, industry on track for over $105 million in 201

(Albuquerque) – Ultra Health, New Mexico’s #1 Cannabis Company, finished the first quarter of 2018 with over $3.7 million in sales, more than any other medical cannabis provider in the program’s 10-year history. The provider’s first quarter sales are a whopping 90 percent higher than its sales during the first quarter of 2017.

During the same period, patient enrollment has increased by 46 percent, therefore validating the provider’s market dominance and increasing market share. In the first three months of 2018 alone, Ultra Health’s revenue increased by 34 percent while patient enrollment increased by 7 percent.

Ultra Health has lead all 35 licensed producers in 2016, 2017 and continues into 2018.

It is estimated the entire medical cannabis industry reached $24 million in sales during the first quarter of the year. Official industry-wide data will be released in early May following the submission of quarterly reports to the New Mexico Department of Health by each provider, which will be no later than April 23, 2018.

As of March 31, 2018, enrollment in the Medical Cannabis Program reached 50,954 patients.

“Patient demand has grown over 113 percent per annum for five consecutive years, which is an undeniable confirmation of the tremendous need and support for medical cannabis among New Mexicans,” said Duke Rodriguez, CEO and President of Ultra Health®. “The acute demand levels will certainly challenge the ability to ensure an adequate supply statewide, particularly for the operators with limited scalability. Fortunately, Ultra Health continues to offer the largest selection of safe, affordable and convenient medical cannabis products.”

Ultra Health filed a complaint against NMDOH to ensure an adequate supply of medical cannabis in August 2016. Santa Fe District Court Judge David K. Thomson is expected to rule on the case at 2:30 p.m. on May 14, 2018 in Santa Fe.

Enrollment is expected to surpass 65,000 patients by year end, and industry revenues are estimated to hit an excess of $105 million in 2018.

Enrollment increases 46 percent over last year, City of Albuquerque to decriminalize cannabis

(Albuquerque) – For the first time, New Mexico’s Medical Cannabis Program exceeded 50,000 patients, reaching 50,954 as of March 31, 2018, according to the New Mexico Department of Health.

The current enrollment is 46 percent higher than the 34,909 patient enrollment as of March 31, 2017. The program has grown by over 16,000 patients in this last year, adding over 4,300 alone in the first quarter of 2018.

Continue reading “New Mexico Medical Cannabis Program Soars Past 50,000 Milestone”

February patient count sees continued increase, 60,000 cardholders expected by year end

(Albuquerque) – Patient enrollment in New Mexico’s Medical Cannabis Program is continuing its accelerated pace into 2018, increasing by 15,167 patients or 45 percent from February 28, 2017 to February 28, 2018.

According to the New Mexico Department of Health, total enrollment reached 48,821 patients at the end of February 2018. The most common qualifying conditions are PTSD, severe chronic pain and cancer.

Continue reading “New Mexico Medical Cannabis Enrollment Up 45 Percent Over Last Year”

Continued patient enrollment growth requires program enhancements to meet increased demand

(Albuquerque) – New Mexico’s Medical Cannabis Program ended January 2018 with 47,840 enrolled patients according to the New Mexico Department of Health report, a 49 percent increase over the same month in 2017. An additional 1,195 patients were added in January 2018 alone, on top of the record gain of 17,599 patients in 2017, confirming the unrelenting need of medical cannabis for tens of thousands of New Mexicans. Continue reading “NM Medical Cannabis Enrollment Up Nearly 50 Percent”

The state’s Medical Cannabis Program grows exponentially despite ongoing challenges

(Albuquerque) – The New Mexico Medical Cannabis Program’s total industry revenues from 2016 to 2017 increased by $35.6 million, resulting in the highest one-year dollar gain in the program’s history. The year ended with $86.2 million in sales and 46,645 enrolled patients, which is a patient increase of 61 percent from December 31, 2016.

The regulated cannabis industry experienced a record 70 percent increase in sales from 2016 to 2017. The rapid growth of the program is reflective of the spirit and resilience of the medical cannabis patients in New Mexico, despite various ongoing challenges to the decade-old program.  

Continue reading “New Mexico Cannabis Program Finishes 2017 with Record Year & Growth”

Albuquerque, NM, Jan. 16, 2018 (GLOBE NEWSWIRE) —

Ultra Health Insert

Ultra Health distributed 230,415 copies of an informational printed media insert to 19 newspapers across New Mexico from January 10, 2018 to January 14, 2018, reaching nearly one third of New Mexican households. The purpose of the insert was to provide New Mexicans with valuable information regarding Ultra Health’s current and future projects. The newspapers were selected by the communities Ultra Health is currently in and its prospective communities. By providing New Mexicans with its upcoming plans, Ultra Health hopes to inspire the state to be proud of one of its most successful and growing industries.

Continue reading “Ultra Health announces nation’s first in-depth, experiential cannabis dispensary and second cultivation site”

Patient participation continues upward momentum, double the rate of Arizona patient growth

(Albuquerque) – Patient enrollment in New Mexico’s Medical Cannabis Program hit 46,645 as of December 31, 2017, finishing the year with a 61 percent increase over the January 1, 2017 cardholder numbers. The New Mexico medical program appears to be growing at nearly twice the pace of neighboring Arizona. Continue reading “New Mexico Medical Cannabis Enrollment Reaches 46,645 By Year End”

Patient numbers experience highest gain in program history despite NMDOH enrollment adjustments

(Albuquerque) – Patient enrollment in New Mexico’s Medical Cannabis Program reached 45,347 as of November 30, 2017, a 77 percent increase and a 19,650 net patient gain over the same period last year.

On an annual basis, this is the highest percentage gain and the greatest net patient increase since the inception of the program in 2007. Continue reading “New Mexico Medical Cannabis Enrollment Sees Record 77 Percent Increase”

Supply remains in jeopardy as patient enrollment increases at double the rate of industry sales

(Albuquerque) – The 35 licensed commercial producers in New Mexico’s Medical Cannabis Program brought in a record $22.1 million for the third quarter of 2017, an increase of 4 percent from the second quarter.

Patient enrollment increased by over 10 percent, from 44,403 to 48,861, during the same quarterly period.

Continue reading “Medical Cannabis Program Continues Growth in Third Quarter”

New Mexico industry leader reaches over one million dollar sales in single month

(Albuquerque) – Ultra Health, New Mexico’s #1 Cannabis Company, achieved $1.1 million in sales for the month of September 2017, the highest single month revenue ever recorded by a New Mexico cannabis provider. It is the first time a licensed New Mexico producer has achieved greater than $1 million for a single month. There are currently 35 licensed commercial medical cannabis producers in New Mexico serving nearly 50,000 patients.

Ultra Health recently opened its eighth location serving six New Mexico counties and became the nation’s largest vertically integrated solely medical cannabis provider.

“The milestone achieved is a direct reflection of how the New Mexico Medical Cannabis Program is sustaining its upward momentum,” said Duke Rodriguez, CEO and President of Ultra Health®. “We remain committed to providing every patient in every county equal access to safe, affordable and convenient medicine. The continued growth of the industry is fully dependent on new products, patients and locations being successfully integrated.”

Patients have responded favorably to Ultra Health’s new pharmaceutical-grade, smokeless medicinal products which include sublingual and oral tablets, vaginal and rectal suppositories, oils, topicals, pastilles and patches.

“We are dedicated to enhancing patient choice, which means giving all patients the healthy advantages of purchasing accurately dosed medications with varied delivery methods, much like you would purchase from your neighborhood pharmacy,” Rodriguez said.

As of September 30, 2017 the New Mexico Department of Health reported 48,861 medical cannabis patients enrolled in the program. Currently, thousands of patients still reside in 14 counties without a full time dispensary. New Mexico is the 5th largest state by area which makes rural access challenging but essential for improved health.  

New Mexico’s medical cannabis industry is expected to reach $90 million in revenue by the end of the current year and hit $205 million by 2020.